Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?

Shalini Arunogiri; Suzanne Nielsen

doi:10.1111/dar.13029

Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	203-204
Number of pages	2
Journal	Drug and Alcohol Review
Volume	39
Issue number	3
DOIs	https://doi.org/10.1111/dar.13029
Publication status	Published - Mar 2020

Keywords

Opioid agonist treatment
fentanyl
buprenorphine
Opioid-related disorder

Access to Document

10.1111/dar.13029

Cite this

@article{19b044cbd071437885dd204ac3e361a6,

title = "Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?",

keywords = "Opioid agonist treatment, fentanyl, buprenorphine, Opioid-related disorder",

author = "Shalini Arunogiri and Suzanne Nielsen",

year = "2020",

month = mar,

doi = "10.1111/dar.13029",

language = "English",

volume = "39",

pages = "203--204",

journal = "Drug and Alcohol Review",

issn = "0959-5236",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Opioid agonist treatment in the time of fentanyl

T2 - What can we learn from emerging evidence?

AU - Arunogiri, Shalini

AU - Nielsen, Suzanne

PY - 2020/3

Y1 - 2020/3

KW - Opioid agonist treatment

KW - fentanyl

KW - buprenorphine

KW - Opioid-related disorder

UR - http://www.scopus.com/inward/record.url?scp=85077910349&partnerID=8YFLogxK

U2 - 10.1111/dar.13029

DO - 10.1111/dar.13029

M3 - Comment / Debate

C2 - 31916289

AN - SCOPUS:85077910349

SN - 0959-5236

VL - 39

SP - 203

EP - 204

JO - Drug and Alcohol Review

JF - Drug and Alcohol Review

IS - 3

ER -

Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?

Keywords

Access to Document

Other files and links

Cite this